false
Catalog
HRS Board Review 2025 New Courses (Reviewers Copy)
Workshop 1_Electrocardio_London_2025_case 10 answe ...
Workshop 1_Electrocardio_London_2025_case 10 answer
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
The correct answer is C. He has Brugada syndrome and his ECG findings were exacerbated by the fever. He should be treated with Tylenol and admitted. So the ECG patent in Brugada syndrome can be highly variable from day to day. It is exacerbated by fever. Here, the fever brought out a type one Brugada syndrome ECG patent. The Brugada syndrome ECG patent is worsened by beta blockers and there's no evidence that beta blockers prevent arrhythmias or sudden cardiac death. Fever can promote arrhythmias as well as the Brugada syndrome ECG patent. Thus, affected patients should be aggressively treated with antipyretics such as Tylenol and monitored if they develop a type one Brugada syndrome patent, especially if they have symptoms suggestive of arrhythmias. Thus, the patient should be admitted to the hospital and monitored. While quinidine can normalize the electrocardiogram in Brugada syndrome patients by decreasing the transient outward potassium current and while quinidine is certainly useful in cases of arrhythmic storm, there is no evidence supporting its use in the primary prevention of arrhythmias and sudden death should somebody need long-term therapy, the only therapy that is proven is the defibrillator. Thank you very much.
Video Summary
The patient has Brugada syndrome, where symptoms and ECG abnormalities can worsen with fever. He should be treated with Tylenol and hospitalized for monitoring. While quinidine can help during arrhythmic storms, it isn't useful for primary prevention of arrhythmias or sudden death. Beta blockers don't prevent these problems and can worsen the condition. Long-term, a defibrillator is the only proven treatment. Fever can exacerbate the syndrome's symptoms, so aggressive antipyretic treatment and monitoring are essential when type one Brugada patterns arise, especially if the patient exhibits arrhythmia-related symptoms.
Keywords
Brugada syndrome
fever
defibrillator
quinidine
arrhythmia
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English